Table 1.
SNPa | BP | Meta-analysis | SWE (n = 9850) | ITA (n = 2589) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
CHR | LD# | A1 | P | OR | P | OR | P | OR | ||
rs900347 | 145726727 | 1 | 1 | A | 0.0285 | 0.90 | 0.0352 | 0.87 | 0.3624 | 0.94 |
rs11800992 | 146501783 | 1 | 2 | A | 0.0093 | 0.82 | 0.0260 | 0.78 | 0.1399 | 0.85 |
rs72691008 | 146708291 | 1 | 3 | A | 0.0017 | 0.69 | 0.0083 | 0.69 | 0.0895 | 0.70 |
rs7514808 | 146570076 | 1 | 4 | A | 0.0286 | 0.89 | 0.0367 | 0.86 | 0.3632 | 0.93 |
rs72706463 | 146615555 | 1 | 5 | A | 0.0458 | 1.29 | 0.1141 | 1.37 | 0.2002 | 1.24 |
rs10453880 | 146693689 | 1 | 6 | T | 0.0065 | 1.26 | 0.1083 | 1.21 | 0.0236 | 1.32 |
rs145465008 | 146630173 | 1 | 7 | C | 0.0293 | 1.51 | 0.4867 | 1.17 | 0.0048 | 2.54 |
rs115153075 | 146978424 | 1 | 8 | T | 0.0006 | 1.48 | 0.0058 | 1.42 | 0.0303 | 1.74 |
rs12096043 | 147060953 | 1 | 9 | T | 0.0001 | 1.84 | 0.0005 | 2.03 | 0.0633 | 1.58 |
rs672619 | 147058575 | 1 | 10 | T | 0.0013 | 1.34 | 0.0374 | 1.32 | 0.0146 | 1.35 |
rs10494248 | 147108260 | 1 | 11 | A | 0.0079 | 1.72 | 0.0270 | 1.68 | 0.1386 | 1.82 |
rs140566115 | 147126437 | 1 | 12 | A | 0.0244 | 1.53 | 0.0335 | 1.66 | 0.3586 | 1.34 |
rs116430961 | 147312516 | 1 | 13 | C | 0.0101 | 1.62 | 0.1335 | 1.44 | 0.0265 | 1.93 |
rs61740912 | 147313970 | 1 | 14 | G | 0.0012 | 1.86 | 0.0098 | 1.81 | 0.0483 | 1.97 |
rs112044341 | 147317235 | 1 | 15 | A | 0.0193 | 1.47 | 0.0577 | 1.46 | 0.1707 | 1.49 |
rs74123747 | 147382534 | 1 | 16 | T | 0.0496 | 1.27 | 0.2194 | 1.20 | 0.0813 | 1.50 |
PPMS primary progressive MS, BOMS bout-onset MS (RRMS + SPMS), OR odds ratio, LD# linkage disequilibrium block, SWE Swedish cohort, ITA Italian cohort, CHR chromosome; P P-value, A1 effect allele, BP base pair (GRCh37/hg19).
aSNP ID highlighted in bold remains significant after Bonferroni correction for multiple testing (p < 7.2 × 10−4).